227 related articles for article (PubMed ID: 14554236)
1. Infections in patients with cancer undergoing chemotherapy: aetiology, prevention, and treatment.
Vento S; Cainelli F
Lancet Oncol; 2003 Oct; 4(10):595-604. PubMed ID: 14554236
[TBL] [Abstract][Full Text] [Related]
2. [Application of the concepts of evidence-based medicine to the evidence on the treatment of febrile neutropenia].
Jarque I; Sanz MA
Enferm Infecc Microbiol Clin; 1999; 17 Suppl 2():95-102. PubMed ID: 10605194
[TBL] [Abstract][Full Text] [Related]
3. Antibiotic treatment of febrile episodes in neutropenic cancer patients. Clinical and economic considerations.
de Lalla F
Drugs; 1997 May; 53(5):789-804. PubMed ID: 9129866
[TBL] [Abstract][Full Text] [Related]
4. Intravenous and oral itraconazole versus intravenous amphotericin B deoxycholate as empirical antifungal therapy for persistent fever in neutropenic patients with cancer who are receiving broad-spectrum antibacterial therapy. A randomized, controlled trial.
Boogaerts M; Winston DJ; Bow EJ; Garber G; Reboli AC; Schwarer AP; Novitzky N; Boehme A; Chwetzoff E; De Beule K;
Ann Intern Med; 2001 Sep; 135(6):412-22. PubMed ID: 11560454
[TBL] [Abstract][Full Text] [Related]
5. The current spectrum of infection in cancer patients with chemotherapy related neutropenia.
Nesher L; Rolston KV
Infection; 2014 Feb; 42(1):5-13. PubMed ID: 23975584
[TBL] [Abstract][Full Text] [Related]
6. Management of the febrile neutropenic patient with cancer.
Gucalp R
Oncology (Williston Park); 1991 Jul; 5(7):137-44, 147; discussion 148. PubMed ID: 1837473
[TBL] [Abstract][Full Text] [Related]
7. [Prevention and treatment of febrile neutropenia].
Montemurro F; Gallicchio M; Aglietta M
Tumori; 1997; 83(2 Suppl):S15-9. PubMed ID: 9235724
[TBL] [Abstract][Full Text] [Related]
8. Summaries for patients. Itraconazole and amphotericin B to treat fungal infections in patients with cancer who are receiving chemotherapy.
Ann Intern Med; 2001 Sep; 135(6):S-39. PubMed ID: 11575279
[No Abstract] [Full Text] [Related]
9. [Prophylactic and empirical treatment of mycoses in neutropenic fever. Report and comments on meta-analysis].
Kalin M; Björkholm M
Lakartidningen; 2001 Apr; 98(16):1899-903. PubMed ID: 11370406
[TBL] [Abstract][Full Text] [Related]
10. [Fungal infections in oncohematology: the role of prophylaxis].
Sobrevilla Calvo P
Drugs Today (Barc); 2010 Apr; 46 Suppl C():7-11. PubMed ID: 20490377
[TBL] [Abstract][Full Text] [Related]
11. Prophylactic action of oral fluconazole against fungal infection in neutropenic patients. A meta-analysis of 16 randomized, controlled trials.
Kanda Y; Yamamoto R; Chizuka A; Hamaki T; Suguro M; Arai C; Matsuyama T; Takezako N; Miwa A; Kern W; Kami M; Akiyama H; Hirai H; Togawa A
Cancer; 2000 Oct; 89(7):1611-25. PubMed ID: 11013378
[TBL] [Abstract][Full Text] [Related]
12. [Antibiotics and antimycotics in oncology].
Krcméry V
Vnitr Lek; 1991; 37(7-8):695-702. PubMed ID: 1755212
[TBL] [Abstract][Full Text] [Related]
13. [Treatment and prevention of infections in cancer patients with neutropenia].
Sinkó J
Magy Onkol; 2011 Sep; 55(3):155-63. PubMed ID: 21918740
[TBL] [Abstract][Full Text] [Related]
14. Low bacterial diet versus control diet to prevent infection in cancer patients treated with chemotherapy causing episodes of neutropenia.
van Dalen EC; Mank A; Leclercq E; Mulder RL; Davies M; Kersten MJ; van de Wetering MD
Cochrane Database Syst Rev; 2012 Sep; (9):CD006247. PubMed ID: 22972091
[TBL] [Abstract][Full Text] [Related]
15. Infectious complications in the cancer patient.
Bodey GP
Curr Probl Cancer; 1977 Jun; 1(12):1-63. PubMed ID: 406117
[No Abstract] [Full Text] [Related]
16. Chemoprophylaxis for the prevention of bacterial and fungal infections.
Donnelly JP
Cancer Treat Res; 1995; 79():45-81. PubMed ID: 8746649
[No Abstract] [Full Text] [Related]
17. Empiric treatment of fungal infections in the neutropenic host. Review of the literature and guidelines for use.
Sugar AM
Arch Intern Med; 1990 Nov; 150(11):2258-64. PubMed ID: 2241435
[TBL] [Abstract][Full Text] [Related]
18. Empirical versus preemptive antifungal therapy for high-risk, febrile, neutropenic patients: a randomized, controlled trial.
Cordonnier C; Pautas C; Maury S; Vekhoff A; Farhat H; Suarez F; Dhédin N; Isnard F; Ades L; Kuhnowski F; Foulet F; Kuentz M; Maison P; Bretagne S; Schwarzinger M
Clin Infect Dis; 2009 Apr; 48(8):1042-51. PubMed ID: 19281327
[TBL] [Abstract][Full Text] [Related]
19. [Empirical antifungal therapy in selected patients with persistent fever and neutropenia].
Cisneros JM; Espigado I; Rivero A; Lozano de León F; Parra J; Collado AR; Lomas JM; Pachón J;
Enferm Infecc Microbiol Clin; 2005 Dec; 23(10):609-14. PubMed ID: 16324551
[TBL] [Abstract][Full Text] [Related]
20. Management of infections during intensive treatment of hematologic malignancies.
Maschmeyer G; Hiddemann W; Link H; Cornely OA; Buchheidt D; Glass B; Adam D
Ann Hematol; 1997; 75(1-2):9-16. PubMed ID: 9322678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
